Phase I/randomized phase II trial of either dasatinib or placebo combined with standard chemoradiotherapy for newly diagnosed glioblastoma multiforme (GBM): Final results of phase I study.
Nadia N. Laack
Research Funding - Bristol-Myers Squibb
Evanthia Galanis
Research Funding - Bristol-Myers Squibb
Clinton Leinweber
No relevant relationships to disclose
Jan C. Buckner
No relevant relationships to disclose
Caterina Giannini
No relevant relationships to disclose
Francois J. Geoffroy
No relevant relationships to disclose
Kurt A. Jaeckle
No relevant relationships to disclose
Jann Nagina Sarkaria
No relevant relationships to disclose